In the context of osteosarcoma several studies have reported that VEGF and SDF-1 are associated with poor prognosis in osteosarcoma [37,52,53] thus resulting in approaches to counteract this growth factor and chemokine as a therapeutical option for osteosarcoma treatment [54]. This evidence concerns the gene CXCL12 and osteosarcoma.